Close Menu

NEW YORK (GenomeWeb) – Mass spec technology firm Newomics has closed a $3.9 million Series A funding round.

The Berkeley, California-based company closed the round on Wednesday, said Daojing Wang, Newomics' founder and CEO, adding that it surpassed its initial target of $3.5 million. The round was led by the Berkeley Catalyst Fund and the Photon Fund.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Following discrimination allegations, NICHD's Constantine Stratakis withdraws from a new position at the Research Institute of the McGill University Health Center, Science reports.

US President Donald Trump has threatened to cut World Health Organization funding over its pandemic response, which would affect its ability to do its work and which he might not be able to do.

The US Securities and Exchange Commission has halted the sales of a handful of stocks over claims made about the coronavirus.

In Nature this week: comparative analyses of single-cell RNA sequencing protocols uncover differences between approaches, and more.

May
06
Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.